Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
‘Weight Management’ Guidance Changes From FDA Could Tip Scales In Obesity Reimbursement Debate
Oct 17 2023
•
By
Sarah Karlin-Smith
Updates to a nearly 20-year old FDA guidance could help manufacturers’ in their quest for obesity drug coverage. • Source: Shutterstock
More from Approval Standards
More from Pathways & Standards